×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
Business Wire
--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel...
47 months ago
AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals
PR Newswire
The transaction was unanimously approved by both the AcelRx and Tetraphase Boards of Directors and is expected to close in the second quarter of...
50 months ago
WilmerHale Advises Tetraphase Pharmaceuticals in Agreement to be Acquired by Melinta Therapeutics
WilmerHale
Tetraphase Pharmaceuticals, Inc. and Melinta Therapeutics announce that they have entered into a definitive merger agreement pursuant to...
47 months ago
Melinta wins bidding war to land deal to acquire Tetraphase
Fierce Biotech
Melinta Therapeutics has struck a deal to buy Tetraphase Pharmaceutica.
47 months ago
Struggling La Jolla sells out to Innoviva for $149M
Fierce Pharma
With sales of blood pressure medicine Giapreza lagging, La Jolla has sold out to royalty management company Innoviva for $149 million.
22 months ago
Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal ...
GlobeNewswire
Tetraphase's lead product, XERAVA™ (eravacycline) is FDA-approved for the treatment of complicated intra-abdominal infections (cIAI), has...
68 months ago
Bidding War Sends Tetraphase Shares Soaring
Yahoo Finance
Shares of nano-cap Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH), which have never really recovered from a steep sell-off triggered by an...
48 months ago
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika ...
FinancialContent
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika Pharma, Pfizer, Novartis,...
11 months ago
FDA Approves New Antibacterial Eravacycline (Xerava)
Medscape
The US Food and Drug Administration (FDA) has approved eravacycline (Xerava, Tetraphase Pharmaceuticals) for treatment of complicated...
68 months ago
Antibiotic Industry: How to Fix Its Infection
Fortune
Commentary: The antibiotics industry is in free fall, with companies like Achaogen and Tetraphase Pharmaceuticals losing funding.
54 months ago